What is NDC 70771-1525?

70771-1525 is the product NDC for Propafenone Hydrochloride, Propafenone hydrochloride 225 mg/1 capsule, extended release, listed with the FDA by Zydus Lifesciences Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Propafenone Hydrochloride?

52 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Propafenone Hydrochloride NDC 70771-1525

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1525Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1525Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1525-5	7077115250570771152505	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1525-5)Marketed from Feb 2, 2022
70771-1525-6	7077115250670771152506	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1525-6)Marketed from Feb 2, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Propafenone Hydrochloride
Generic name (nonproprietary): propafenone hydrochloride
Active ingredients: Propafenone hydrochloride — 225 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214184
Marketing start: Feb 2, 2022
Listing expires: Dec 31, 2027
Identifiers: Product ID 70771-1525_e7389f3e-074b-44ca-b767-5520390265e5SPL ID e7389f3e-074b-44ca-b767-5520390265e5SPL set ID b41ec863-5734-41a3-9837-6c0a962ec6ebRxCUI 861156, 861164, 861171UNII 33XCH0HOCDUPC 0370771152766
Pharmacologic class: Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771152505 followed by a unit qualifier and the quantity

Package 70771-1525-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 11, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Propafenone hydrochloride extended-release capsules are indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease. Usage Considerations: The use of propafenone hydrochloride extended-release capsules in patients with permanent AF or in patients exclusively with atrial flutter or paroxysmal supraventricular tachycardia (PSVT) has not been evaluated. Do not use propafenone hydrochloride extended-release capsules to control ventricular rate during AF. Some patients with atrial flutter treated with propafenone have developed 1:1 conduction, producing an increase …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1525

What is NDC 70771-1525?: 70771-1525 is the product NDC for Propafenone Hydrochloride, Propafenone hydrochloride 225 mg/1 capsule, extended release, listed with the FDA by Zydus Lifesciences Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Propafenone Hydrochloride.
What is the active ingredient?: Propafenone hydrochloride.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Propafenone Hydrochloride?: 52 other product NDCs are listed under this name. See all Propafenone Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Propafenone Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Propafenone Hydrochloride	Propafenone hydrochloride 150 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-930	60687-0930-01
Propafenone Hydrochloride	Propafenone hydrochloride 300 mg/1	Tablet, Film coatedOral	Strides Pharma Science Limited	64380-246	64380-0246-01
Propafenone Hydrochloride	Propafenone hydrochloride 225 mg/1	Tablet, Film coatedOral	Strides Pharma Science Limited	64380-268	64380-0268-0164380-0268-02
Propafenone Hydrochloride	Propafenone hydrochloride 150 mg/1	Tablet, Film coatedOral	Strides Pharma Science Limited	64380-269	64380-0269-0164380-0269-02
Propafenone Hydrochloride	Propafenone hydrochloride 225 mg/1	Capsule, Extended releaseOral	Aurobindo Pharma Limited	59651-276	59651-0276-0559651-0276-6059651-0276-90
Propafenone Hydrochloride	Propafenone hydrochloride 325 mg/1	Capsule, Extended releaseOral	Aurobindo Pharma Limited	59651-277	59651-0277-0559651-0277-6059651-0277-90
Propafenone Hydrochloride	Propafenone hydrochloride 425 mg/1	Capsule, Extended releaseOral	Aurobindo Pharma Limited	59651-278	59651-0278-0559651-0278-6059651-0278-90
Propafenone Hydrochloride	Propafenone hydrochloride 150 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-709	60687-0709-01
Propafenone Hydrochloride	Propafenone hydrochloride 300 mg/1	Tablet, Film coatedOral	Strides Pharma Science Limited	64380-163	64380-0163-01
Propafenone Hydrochloride	Propafenone hydrochloride 225 mg/1	Tablet, Film coatedOral	Strides Pharma Science Limited	64380-164	64380-0164-0164380-0164-02

All 53 Propafenone Hydrochloride NDCs

Other NDCs under ANDA 214184

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214184
Product	Strength	Form · route	Labeler	Product NDC
Propafenone Hydrochloride	Propafenone hydrochloride 225 mg/1	Capsule, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-522
Propafenone Hydrochloride	Propafenone hydrochloride 325 mg/1	Capsule, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-523
Propafenone Hydrochloride	Propafenone hydrochloride 425 mg/1	Capsule, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-524
Propafenone Hydrochloride	Propafenone hydrochloride 325 mg/1	Capsule, Extended releaseOral	Zydus Lifesciences Limited	70771-1526
Propafenone Hydrochloride	Propafenone hydrochloride 425 mg/1	Capsule, Extended releaseOral	Zydus Lifesciences Limited	70771-1527